Mirum Pharmaceuticals, Inc. - common stock (MIRM): Price and Financial Metrics


Mirum Pharmaceuticals, Inc. - common stock (MIRM): $18.71

-1.86 (-9.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MIRM POWR Grades


  • MIRM scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.75% of US stocks.
  • The strongest trend for MIRM is in Growth, which has been heading up over the past 179 days.
  • MIRM ranks lowest in Momentum; there it ranks in the 12th percentile.

MIRM Stock Summary

  • MIRM's went public 2.7 years ago, making it older than merely 7.68% of listed US stocks we're tracking.
  • MIRM's price/sales ratio is 37.21; that's higher than the P/S ratio of 95.27% of US stocks.
  • With a year-over-year growth in debt of 160.31%, Mirum Pharmaceuticals Inc's debt growth rate surpasses 93.17% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Mirum Pharmaceuticals Inc, a group of peers worth examining would be MRUS, FULC, SURF, ADAP, and MIST.
  • Visit MIRM's SEC page to see the company's official filings. To visit the company's web site, go to mirumpharma.com.

MIRM Valuation Summary

  • MIRM's price/sales ratio is 45.1; this is 297.36% higher than that of the median Healthcare stock.
  • MIRM's price/sales ratio has moved NA NA over the prior 26 months.
  • Over the past 26 months, MIRM's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for MIRM.

Stock Date P/S P/B P/E EV/EBIT
MIRM 2021-08-31 45.1 5.2 -3.2 -3.6
MIRM 2021-08-30 44.4 5.1 -3.2 -3.6
MIRM 2021-08-27 45.1 5.2 -3.2 -3.6
MIRM 2021-08-26 43.1 5.0 -3.1 -3.5
MIRM 2021-08-25 42.1 4.8 -3.0 -3.4
MIRM 2021-08-24 41.3 4.7 -3.0 -3.4

MIRM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MIRM has a Quality Grade of C, ranking ahead of 49.16% of graded US stocks.
  • MIRM's asset turnover comes in at 0.052 -- ranking 319th of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows MIRM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.052 1 -0.949
2021-03-31 0.000 NA -1.229
2020-12-31 0.000 NA -1.146
2020-09-30 0.000 NA -0.934
2020-06-30 0.000 NA -0.781
2020-03-31 0.000 NA -0.694

MIRM Price Target

For more insight on analysts targets of MIRM, see our MIRM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $51.33 Average Broker Recommendation 1.29 (Strong Buy)

MIRM Stock Price Chart Interactive Chart >

Price chart for MIRM

MIRM Price/Volume Stats

Current price $18.71 52-week high $28.65
Prev. close $20.57 52-week low $12.82
Day low $18.70 Volume 1,839,700
Day high $20.76 Avg. volume 208,619
50-day MA $23.64 Dividend yield N/A
200-day MA $19.73 Market Cap 595.63M

Mirum Pharmaceuticals, Inc. - common stock (MIRM) Company Bio


Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.


MIRM Latest News Stream


Event/Time News Detail
Loading, please wait...

MIRM Latest Social Stream


Loading social stream, please wait...

View Full MIRM Social Stream

Latest MIRM News From Around the Web

Below are the latest news stories about Mirum Pharmaceuticals Inc that investors may wish to consider to help them evaluate MIRM as an investment opportunity.

Mirum Pharmaceuticals Inc. (NASDAQ: MIRM) Stock Jumped 29.45% Over A Month Are There Any Chances Of Growth?

During the last session, Mirum Pharmaceuticals Inc. (NASDAQ:MIRM)s traded shares were 0.35 million. At the end of the trading day, the stocks price was $23.12, reflecting an intraday gain of 1.67% or $0.38. The 52-week high for the MIRM share is $23.35, that puts it down -0.99 from that peak though still a striking 44.55% Mirum Pharmaceuticals Inc. (NASDAQ: MIRM) Stock Jumped 29.45% Over A Month Are There Any Chances Of Growth? Read More »

Marketing Sentinel | February 19, 2022

Mirum Pharmaceuticals' (NASDAQ:MIRM) investors will be pleased with their 14% return over the last year

The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...

Yahoo | February 17, 2022

Mirum Pharmaceuticals grants stock options under inducement plan

Mirum Pharmaceuticals (MIRM) granted two new employees non-qualified stock options to buy 14.2K common shares and 7.1K restricted stock units under the company''s 2020 Inducement…

Seeking Alpha | February 11, 2022

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., February 11, 2022--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo | February 11, 2022

Mirum Pharmaceuticals to Present at SVB Leerink 11th Annual Global Healthcare Conference

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Present at SVB Leerink 11th Annual Global Healthcare Conference

Business Wire | February 9, 2022

Read More 'MIRM' Stories Here

MIRM Price Returns

1-mo -23.88%
3-mo -17.61%
6-mo 19.32%
1-year 6.01%
3-year N/A
5-year N/A
YTD 17.30%
2021 -8.65%
2020 -28.79%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5667 seconds.